Gene: ERCC4

2072
ERCC11|FANCQ|RAD1|XFEPS|XPF
ERCC excision repair 4, endonuclease catalytic subunit
protein-coding
16p13.12
Ensembl:ENSG00000175595 MIM:133520 Vega:OTTHUMG00000048194 UniprotKB:Q92889
NG_011442.1
PubMed
0   ANCO-SNPs
ND
18   
NA (AD)  NA (ND)   (Frontal_Cortex)
8.079e-2 (AD)  9.148e-2 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
FAM208B0.862
ZNF5070.848
RBAK0.845
LCOR0.844
MGA0.843
TAF20.843
PIKFYVE0.84
JRKL0.838
LARP40.837
CHD90.836

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.465
OR4F29-0.422
SPRR2D-0.263
RSPO1-0.245
COX4I2-0.238
SPRR2A-0.234
OR4F16-0.234
NANOGNB-0.223
CLIC3-0.221
IFNG-0.217

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0163923,3'-diindolylmethane"3,3'-diindolylmethane results in increased expression of ERCC4 mRNA"16192472
C0251603-aminobenzamide3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]22228707
C0251603-aminobenzamide3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 protein]22228707
C0251603-aminobenzamide3-aminobenzamide results in decreased expression of ERCC4 mRNA22228707
C0251603-aminobenzamide3-aminobenzamide results in decreased expression of ERCC4 protein22228707
C0251603-aminobenzamide3-aminobenzamide inhibits the reaction [Streptozocin results in increased expression of ERCC4 mRNA]22228707
D000082AcetaminophenAcetaminophen affects the expression of ERCC4 mRNA25064622
D000082AcetaminophenAcetaminophen results in decreased expression of ERCC4 mRNA26690555
D000082AcetaminophenAcetaminophen affects the expression of ERCC4 mRNA17562736
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of ERCC4 mRNA19770486
D000638AmiodaroneAmiodarone affects the expression of ERCC4 mRNA25064622
D001151ArsenicArsenic results in decreased expression of ERCC4 mRNA12569548
C006632arsenic trioxidearsenic trioxide results in increased expression of ERCC4 mRNA17530438
D001205Ascorbic Acid[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC4 mRNA17917374
C072019benzo(a)pyrene diolepoxide Ibenzo(a)pyrene diolepoxide I results in increased expression of ERCC4 mRNA27694624
C072019benzo(a)pyrene diolepoxide Ibenzo(a)pyrene diolepoxide I results in increased expression of ERCC4 protein27694624
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of ERCC4 mRNA28461126
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of ERCC4 mRNA19770486
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ERCC4 mRNA"28593498
C006780bisphenol Abisphenol A affects the expression of ERCC4 mRNA21786754
C006780bisphenol A[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ERCC4 mRNA28628672
C006780bisphenol Abisphenol A results in increased expression of ERCC4 mRNA25181051
C000611646bisphenol F[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERCC4 mRNA28628672
D001761BleomycinERCC4 protein affects the susceptibility to Bleomycin22007867
D001761Bleomycin[ERCC4 protein binds to ERCC1 protein] which results in increased susceptibility to Bleomycin22007867
D000069286BortezomibERCC4 gene SNP results in increased susceptibility to Bortezomib20864405
D002104CadmiumCadmium results in increased expression of ERCC4 mRNA24376830
D002166CamptothecinERCC4 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein]]21227924
D002166CamptothecinERCC4 protein results in decreased susceptibility to Camptothecin21227924
D002746ChlorpromazineChlorpromazine affects the expression of ERCC4 mRNA25064622
C057270cisplatin-DNA adductERCC4 mRNA results in decreased abundance of cisplatin-DNA adduct21452186
D002994ClofibrateClofibrate results in increased expression of ERCC4 mRNA12851107
D003035CobaltCobalt results in increased expression of ERCC4 mRNA22147119
C060728cobalt oxidecobalt oxide analog results in increased expression of ERCC4 mRNA24821434
D003471CuprizoneCuprizone results in increased expression of ERCC4 mRNA27523638
D003474CurcuminCurcumin inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]22228707
D003474CurcuminCurcumin inhibits the reaction [Glucose results in increased expression of ERCC4 protein]22228707
D003474CurcuminCurcumin results in decreased expression of ERCC4 mRNA22228707
D003474CurcuminCurcumin results in decreased expression of ERCC4 protein22228707
D003474CurcuminCurcumin inhibits the reaction [Streptozocin results in increased expression of ERCC4 mRNA]22228707
D016572CyclosporineCyclosporine affects the expression of ERCC4 mRNA25064622
C089595cylindrospermopsincylindrospermopsin results in increased expression of ERCC4 mRNA23726867
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ERCC4 mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERCC4 mRNA28628672
D002945CisplatinCisplatin results in increased expression of ERCC4 mRNA21996734
D002945CisplatinCisplatin results in increased expression of ERCC4 protein21996734
D002945CisplatinDUSP6 inhibits the reaction [Cisplatin results in increased expression of ERCC4 mRNA]21996734
D002945Cisplatin[ERCC1 protein binds to ERCC4 protein] which results in decreased susceptibility to Cisplatin21357694
D002945CisplatinERCC4 mRNA results in decreased susceptibility to Cisplatin21452186
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC4 mRNA17917374
D004785Environmental PollutantsERCC4 gene SNP affects the susceptibility to Environmental Pollutants24036326
C045651epigallocatechin gallateepigallocatechin gallate inhibits the reaction [potassium chromate(VI) results in decreased expression of ERCC4 mRNA]22079256
C045651epigallocatechin gallate[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ERCC4 mRNA22079256
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of ERCC4 mRNA25064622
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of ERCC4 mRNA17662478
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of ERCC4 mRNA17555576
D005557FormaldehydeERCC4 gene mutant form results in increased susceptibility to Formaldehyde22186232
C069837fullerene C60fullerene C60 results in increased expression of ERCC4 mRNA19167457
D005947Glucose3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]22228707
D005947Glucose3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 protein]22228707
D005947GlucoseCurcumin inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]22228707
D005947GlucoseCurcumin inhibits the reaction [Glucose results in increased expression of ERCC4 protein]22228707
D005947GlucoseERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 mRNA]22228707
D005947GlucoseERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 protein]22228707
D005947GlucoseERCC4 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]22228707
D005947GlucoseERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 mRNA]22228707
D005947GlucoseERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 protein]22228707
D005947GlucoseERCC4 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]22228707
D005947GlucoseERCC4 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]22228707
D005947GlucoseGlucose results in increased expression of ERCC4 mRNA22228707
D005947GlucoseGlucose results in increased expression of ERCC4 protein22228707
D005947Glucosetrichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]22228707
D005947Glucosetrichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 protein]22228707
D006861Hydrogen PeroxideERCC4 protein affects the susceptibility to Hydrogen Peroxide22007867
D006861Hydrogen Peroxide[ERCC4 protein binds to ERCC1 protein] which results in increased susceptibility to Hydrogen Peroxide22007867
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ERCC4 mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERCC4 mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ERCC4 mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERCC4 mRNA28628672
C561695(+)-JQ1 compound(+)-JQ1 compound results in increased expression of ERCC4 mRNA25961927
C011890kojic acid[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC4 mRNA17917374
C482199lipopolysaccharide, E coli O55-B5"lipopolysaccharide, E coli O55-B5 results in decreased expression of ERCC4 mRNA"19917589
D058955MetalloidsERCC4 gene SNP affects the susceptibility to Metalloids24036326
D008670MetalsERCC4 gene SNP affects the susceptibility to Metals24036326
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of ERCC4 mRNA23458150
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of ERCC4 mRNA28001369
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in increased expression of ERCC4 mRNA26011545
D008770MethylnitrosoureaMethylnitrosourea results in decreased expression of ERCC4 mRNA16616109
D008770MethylnitrosoureaMethylnitrosourea results in increased expression of ERCC4 mRNA16616109
D015376NimustineERCC4 protein results in decreased susceptibility to Nimustine26418950
C030110oxaliplatinERCC4 protein affects the susceptibility to oxaliplatin16773204
D010126OzoneOzone results in increased expression of ERCC4 mRNA28652203
D010269ParaquatERCC4 protein affects the susceptibility to Paraquat22007867
D010269Paraquat[ERCC4 protein binds to ERCC1 protein] which results in increased susceptibility to Paraquat22007867
D010269ParaquatParaquat affects the expression of ERCC4 mRNA25064622
D052638Particulate MatterParticulate Matter results in increased expression of ERCC4 mRNA24769257
C506614PD 0325901PD 0325901 results in increased expression of ERCC4 mRNA21996734
D010416PentachlorophenolPentachlorophenol results in increased expression of ERCC4 mRNA18486366
D010578PetroleumERCC4 gene SNP affects the susceptibility to Petroleum22102698
C058305phenethyl isothiocyanatephenethyl isothiocyanate results in increased expression of ERCC4 mRNA20442190
D010936Plant ExtractsPlant Extracts results in increased expression of ERCC4 mRNA23557933
C019536potassium bromatepotassium bromate results in decreased expression of ERCC4 mRNA22539617
C027373potassium chromate(VI)epigallocatechin gallate inhibits the reaction [potassium chromate(VI) results in decreased expression of ERCC4 mRNA]22079256
C027373potassium chromate(VI)[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ERCC4 mRNA22079256
C027373potassium chromate(VI)potassium chromate(VI) results in decreased expression of ERCC4 mRNA22079256
C027373potassium chromate(VI)potassium chromate(VI) results in increased expression of ERCC4 mRNA22714537
D017382Reactive Oxygen Species[ERCC4 protein binds to ERCC1 protein] which results in decreased activity of Reactive Oxygen Species22007867
C547185riccardin Driccardin D results in increased expression of ERCC4 mRNA24069304
C017947sodium arsenitesodium arsenite results in increased expression of ERCC4 mRNA22714537
D012999SomanSoman results in decreased expression of ERCC4 mRNA19281266
D053260SootSoot results in decreased expression of ERCC4 mRNA21914721
D013311Streptozocin3-aminobenzamide inhibits the reaction [Streptozocin results in increased expression of ERCC4 mRNA]22228707
D013311StreptozocinCurcumin inhibits the reaction [Streptozocin results in increased expression of ERCC4 mRNA]22228707
D013311StreptozocinStreptozocin results in increased expression of ERCC4 mRNA22228707
D013311StreptozocinStreptozocin results in increased expression of ERCC4 protein22228707
D010042OuabainOuabain results in decreased expression of ERCC4 mRNA24124520
C016766sulforafansulforafan results in increased expression of ERCC4 mRNA20442190
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of ERCC4 mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of ERCC4 mRNA19770486
D013752TetracyclineTetracycline affects the expression of ERCC4 mRNA25064622
D013853ThioacetamideThioacetamide affects the expression of ERCC4 mRNA25064622
C012589trichostatin Atrichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]22228707
C012589trichostatin Atrichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 protein]22228707
C012589trichostatin Atrichostatin A results in decreased expression of ERCC4 mRNA22228707
C012589trichostatin Atrichostatin A results in increased expression of ERCC4 mRNA24935251
D014635Valproic AcidValproic Acid affects the expression of ERCC4 mRNA25064622
D014635Valproic AcidValproic Acid results in decreased expression of ERCC4 mRNA28001369
D014635Valproic AcidValproic Acid results in increased expression of ERCC4 mRNA24935251
C521013veliparibERCC4 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein]]21227924
D014752Vinyl ChlorideERCC4 5' UTR SNP affects the susceptibility to Vinyl Chloride21216194

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0000014single-stranded DNA endodeoxyribonuclease activity-IBA21873635  
GO:0001094TFIID-class transcription factor binding-IEA-  
GO:0003677DNA bindingcontributes_toIDA14734547  
GO:0003684damaged DNA binding-IBA21873635  
GO:0003684damaged DNA binding-IMP11790111  
GO:0003697single-stranded DNA binding-IBA21873635  
GO:0003697single-stranded DNA binding-IDA10413517  
GO:0004520endodeoxyribonuclease activity-IDA10413517  14734547  
GO:0004520endodeoxyribonuclease activitycontributes_toIDA8797827  
GO:0004520endodeoxyribonuclease activity-IMP17055345  
GO:0005515protein binding-IPI7559382  12571280  14690602  16338413  17055345  17289582  
18812185  19595721  19595722  19596235  19596236  24012755  
24780295  
GO:0008022protein C-terminus binding-IPI9722633  
GO:0010521telomerase inhibitor activityNOTIDA18812185  
GO:0042802identical protein binding-IPI22483113  
GO:0047485protein N-terminus binding-IPI14734547  
GO:19905993' overhang single-stranded DNA endodeoxyribonuclease activitycontributes_toIMP14690602  
GO ID GO Term Qualifier Evidence PubMed
GO:0000712resolution of meiotic recombination intermediates-IBA21873635  
GO:0000723telomere maintenance-IGI17055345  
GO:0000723telomere maintenance-IMP14690602  
GO:0000724double-strand break repair via homologous recombination-IBA21873635  
GO:0000724double-strand break repair via homologous recombination-IMP14728600  
GO:0006281DNA repair-IGI17055345  
GO:0006281DNA repair-IMP19596235  
GO:0006283transcription-coupled nucleotide-excision repair-TAS-  
GO:0006289nucleotide-excision repair-IDA10644440  
GO:0006289nucleotide-excision repair-IMP8797827  
GO:0006293nucleotide-excision repair, preincision complex stabilization-TAS-  
GO:0006295nucleotide-excision repair, DNA incision, 3'-to lesion-IMP11790111  
GO:0006296nucleotide-excision repair, DNA incision, 5'-to lesion-IBA21873635  
GO:0006296nucleotide-excision repair, DNA incision, 5'-to lesion-IMP11790111  14728600  
GO:0006296nucleotide-excision repair, DNA incision, 5'-to lesion-TAS-  
GO:0006303double-strand break repair via nonhomologous end joining-IMP14690602  
GO:0009411response to UV-IMP16678501  
GO:0009650UV protection-IEA-  
GO:0032205negative regulation of telomere maintenance-IMP17055345  
GO:0033683nucleotide-excision repair, DNA incision-IDA10413517  
GO:0033683nucleotide-excision repair, DNA incision-TAS-  
GO:0034644cellular response to UV-IGI17055345  
GO:0036297interstrand cross-link repair-TAS-  
GO:0051974negative regulation of telomerase activityNOTIDA18812185  
GO:0061819telomeric DNA-containing double minutes formation-IMP14690602  
GO:0070911global genome nucleotide-excision repair-TAS-  
GO:1901255nucleotide-excision repair involved in interstrand cross-link repair-IBA21873635  
GO:1904357negative regulation of telomere maintenance via telomere lengthening-IDA18812185  
GO:1905765negative regulation of protection from non-homologous end joining at telomere-IMP14690602  
GO:1905768negative regulation of double-stranded telomeric DNA binding-IDA18812185  
GO ID GO Term Qualifier Evidence PubMed
GO:0000109nucleotide-excision repair complex-IDA10644440  
GO:0000110nucleotide-excision repair factor 1 complex-IBA21873635  
GO:0000110nucleotide-excision repair factor 1 complex-IDA10413517  
GO:0000781chromosome, telomeric region-IDA14690602  
GO:0000784nuclear chromosome, telomeric region-IDA14690602  
GO:0005634nucleus-IDA12571280  
GO:0005654nucleoplasm-TAS-  
GO:0005669transcription factor TFIID complex-IEA-  
GO:0070522ERCC4-ERCC1 complex-IDA14690602  17055345  
KEGG ID KEGG Term
hsa03420Nucleotide excision repair
Reactome ID Reactome Term Evidence
R-HSA-5685938HDR through Single Strand Annealing (SSA)TAS
R-HSA-5693532DNA Double-Strand Break RepairTAS
R-HSA-5693538Homology Directed RepairTAS
R-HSA-5693567HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)TAS
R-HSA-5696395Formation of Incision Complex in GG-NERTAS
R-HSA-5696398Nucleotide Excision RepairTAS
R-HSA-5696399Global Genome Nucleotide Excision Repair (GG-NER)TAS
R-HSA-5696400Dual Incision in GG-NERTAS
R-HSA-6781827Transcription-Coupled Nucleotide Excision Repair (TC-NER)TAS
R-HSA-6782135Dual incision in TC-NERTAS
R-HSA-6783310Fanconi Anemia PathwayTAS
R-HSA-73894DNA RepairTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
23435956Decreased expression of DNA repair genes (XRCC1, ERCC1, ERCC2, and ERCC4) in squamous intraepithelial lesion and invasive squamous cell carcinoma of the cervix. (2013 May)Bajpai DMol Cell Biochem
18544627Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. (2008 Jun 15)McWilliams RRCancer Res
24651674Contribution of environment and genetics to pancreatic cancer susceptibility. (2014)Hocevar BAPLoS One
24582975Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA. (2014 May 25)Lu BGene
22573488EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients. (2013 Jan 15)Yang SYInt J Cancer
16284380Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. (2005 Nov)Matullo GCancer Epidemiol Biomarkers Prev
18026184NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans. (2008)Hooker SProstate Cancer Prostatic Dis
16537713Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. (2006 Mar)Garcia-Closas MCancer Epidemiol Biomarkers Prev
23537993Tagging SNPs in the ERCC4 gene are associated with gastric cancer risk. (2013 May 25)Chu HGene
16492920Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. (2006 Feb)Huang WYCancer Epidemiol Biomarkers Prev
19902366Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. (2010 Feb)Agalliu ICancer Causes Control
28415781Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype. (2017 May 30)Carrera-Lasfuentes POncotarget
19444904Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. (2009 Sep 15)Abbasi RInt J Cancer
21622940Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. (2011 Aug)Roberts MRCarcinogenesis
18709642Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. (2008 Nov 1)Chang JSInt J Cancer
26617899Association of NER pathway gene polymorphisms with susceptibility to laryngeal cancer in a Chinese population. (2015)Sun YInt J Clin Exp Pathol
28464886A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells. (2017 May 2)Yeo JBMC Cancer
16806437Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association. (2006 Dec)Weiss JMGynecol Oncol